Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Checkpoint Therapeutics, Inc.
Waltham, MA
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-251005) and Form S-8 (No. 333-216856, No. 333-221488 and No. 333-251000) of Checkpoint Therapeutics, Inc. of our report dated March 28, 2022, relating to the financial statements which appears in this Annual Report on Form 10-K.
/s/ BDO USA, LLP |
| |
| | |
New York, NY | | |
March 28, 2022 | | |